No offence but that sounds delusional.
Demoralisation of shareholders is due to the actions of a company where they focus more on marketing themselves to keep up with the constant funding cycles rather than focusing on monetising their IP as efficiently as possible.
You raised a good question. Why do they have a marketing department? They don't have anything to sell. Are 10m a quarter in staff wages in line with a small R&D based device company? Wayne and management have experience in large pharma companies, but AVR isn't one. They need to learn to crawl before they can walk.
Ann: Trading Halt, page-57
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
0.000(0.00%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 84 | $17.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.65 | 1279 | 3 |
View Market Depth
| Last trade - 13.01pm 23/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable